We have located links that may give you full text access.
Tuberculosis recurrence over 7-year follow-up period in successfully treated patients in a routine programme setting in China: a prospective longitudinal study.
International Journal of Infectious Diseases : IJID 2021 July 29
OBJECTIVES: To determine tuberculosis (TB) recurrence in previously successfully treated patients in routine program setting and baseline characteristics associated with TB recurrence.
METHODS: A prospective longitudinal study in Jiangxi Province, China. Patients, ≥14 years old, were consecutively registered and were followed-up for 7-year to assess TB recurrence against patients' individual baseline data that was entered into a database at TB registration.
RESULTS: There were 800 TB patients registered at baseline and 634 (79.2%) of them completed anti-TB treatments. Fifty nine (9.3%) died and 21 (3.3%) were lost to follow-up over the follow-up period. There were 96 patients with recurrent episodes (total incidence 15.2% or annual incidence 2,200/100,000). Of the recurrent cases, 53 (55.2%) happened within 2-year after completion of anti-TB treatments. After controlling confounding factors, risk of TB recurrence was significantly higher in age range 34-73 years (P<0.01) and current smokers (P<0.01).
CONCLUSIONS: Overall recurrence rate among previously treated TB patients was much higher compared to initial incidence in the same population (61-98/100,000) and settings with similar TB incidence. TB programs should consider closer monitoring for these patients for early detection of recurrence. Particular attention should be given to those between 34-73 years and those who use tobacco products.
METHODS: A prospective longitudinal study in Jiangxi Province, China. Patients, ≥14 years old, were consecutively registered and were followed-up for 7-year to assess TB recurrence against patients' individual baseline data that was entered into a database at TB registration.
RESULTS: There were 800 TB patients registered at baseline and 634 (79.2%) of them completed anti-TB treatments. Fifty nine (9.3%) died and 21 (3.3%) were lost to follow-up over the follow-up period. There were 96 patients with recurrent episodes (total incidence 15.2% or annual incidence 2,200/100,000). Of the recurrent cases, 53 (55.2%) happened within 2-year after completion of anti-TB treatments. After controlling confounding factors, risk of TB recurrence was significantly higher in age range 34-73 years (P<0.01) and current smokers (P<0.01).
CONCLUSIONS: Overall recurrence rate among previously treated TB patients was much higher compared to initial incidence in the same population (61-98/100,000) and settings with similar TB incidence. TB programs should consider closer monitoring for these patients for early detection of recurrence. Particular attention should be given to those between 34-73 years and those who use tobacco products.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app